Celldex Therapeutics buy UBS Group AG
Start price
10.06.26
/
50%
€25.38
Target price
10.06.27
€38.97
Performance (%)
20.96%
Price
08:11
?
Summary
This prediction is currently active. The prediction currently has a performance of 20.96%. This prediction currently runs until 10.06.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 0.590% | 0.590% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by UBS_Group_AG for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by UBS Group AG from $38.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat